Mark Garzotto, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer (NCT03753243) | Mark Garzotto, MD | 2018-12-03 |
Track Mark Garzotto, MD automatically
Every clearance here is in the API, with alerts when new ones post.